Mecapegfilgrastim for prophylaxis of febrile neutropenia in children and adolescents with rhabdomyosarcoma or Ewing sarcoma: a prospective, single-arm, pilot study

Abstract Background The chemotherapy regimens recommended for both rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) patients are myelosuppressive and can reduce the absolute neutrophil count (ANC) and subsequently increase the risk of febrile neutropenia (FN). However, only a few studies have focused o...

詳細記述

書誌詳細

主要な著者:	Wen Zhao, Yuchen Zhou, Xisi Wang, Peiyi Yang, Cheng Huang, Xiaoli Ma, Yan Su, Rui Zhang
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2024-08-01
シリーズ:	BMC Cancer
主題:	Rhabdomyosarcoma Ewing sarcoma Febrile neutropenia Granulocyte colony-stimulating factor Pegfilgrastim
オンライン･アクセス:	https://doi.org/10.1186/s12885-024-12766-w
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!